FAO AGRIS - International System for Agricultural Science and Technology

ETAR antagonist ZD4054 exhibits additive effects with aromatase inhibitors and fulvestrant in breast cancer therapy, and improves in vivo efficacy of anastrozole

2010

Smollich, Martin | Götte, Martin | Fischgräbe, Jeanett | Macedo, Luciana F | Brodie, Angela | Chen, Shiuan | Radke, Isabel | Kiesel, L. | Wülfing, Pia


Bibliographic information
Publisher
American Society for Nutrition
Other Subjects
Time factors; Cell movement; Tamoxifen; Breast neoplasms; Dose-response relationship; Drug; Breast neoplasms; Endothelin a; Endothelin-1; Neoplastic; Endothelin; Endothelin a receptor antagonists; Ednra; Cell line; Tumor; Female; Estrogen antagonists; Antineoplastic combined chemotherapy protocols; Cell proliferation; Neoplasm invasiveness; Zd4054; Administration & dosage; Tumor burden; Analogs & derivatives; Drug effects; Aromatase inhibitors; Nude; Et-1; Aromatase inhibitors; Nitriles; Xenograft model antitumor assays; Pyrrolidines
Language
English
Type
Journal Article; Text

2024-02-29
MODS
Data Provider
Lookup at Google Scholar
If you notice any incorrect information relating to this record, please contact us at [email protected]